Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1980 Sep;10(3):273-9.
doi: 10.1111/j.1365-2125.1980.tb01755.x.

Intersubject and dose-related variability after intravenous administration of erythromycin

Clinical Trial

Intersubject and dose-related variability after intravenous administration of erythromycin

K L Austin et al. Br J Clin Pharmacol. 1980 Sep.

Abstract

1 It is well-known that considerable variability and unpredictability in serum concentrations results from orally administered erythromycin. 2 Disposition kinetics and their variability were studies in 24 healthy subjects after a single dose of erythromycin lactobionate and four doses were studied to evaluate dose-related variability in five other subjects. 3 Erythromycin kinetics were adequately described by a classical two compartment open model with little intersubject variability. 4 Dose-related variability occurred. Clearance was independent of dose but T1/2 beta and Vdss increased with dose. 5 Data are presented to show that non-invasive sampling of urine and saliva are of limited value in studying erythromycin pharmacokinetics.

PubMed Disclaimer

References

    1. Biochem Pharmacol. 1965 Jul;14(7):1049-58 - PubMed
    1. Med J Aust. 1969 Mar 1;1(9):449-51 - PubMed
    1. J Pharm Sci. 1972 Mar;61(3):425-8 - PubMed
    1. J Pharm Sci. 1973 Jul;62(7):1074-7 - PubMed
    1. J Pharm Sci. 1976 Mar;65(3):417-9 - PubMed

LinkOut - more resources